These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22271988)

  • 21. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND) for Lesions in the Minipig.
    Skydsgaard M
    Toxicol Pathol; 2016 Apr; 44(3):480-1. PubMed ID: 26534938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al.
    Tripathi NK; Schultze AE; Pearson RC; Everds NE; Elliott GS; Ramaiah L; Wells MY; Latimer KS; Walter GL; Katavolos P; Collins ND; Tarrant J; Walker DB; Topper MJ; Jordan HL; O'Rourke LG; Guilpin VB; Brockus CW; Wilcox AL; Clemo FA; Smith GS; Reagan WJ; McCartney JE
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):39. PubMed ID: 21676604
    [No Abstract]   [Full Text] [Related]  

  • 23. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of the Minipig.
    Skydsgaard M; Dincer Z; Haschek WM; Helke K; Jacob B; Jacobsen B; Jeppesen G; Kato A; Kawaguchi H; McKeag S; Nelson K; Rittinghausen S; Schaudien D; Vemireddi V; Wojcinski ZW
    Toxicol Pathol; 2021 Jan; 49(1):110-228. PubMed ID: 33393872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific and Regulatory Policy Committee Points to Consider*: The Toxicologic Pathologist's Role in the 3Rs.
    Hukkanen RR; Dybdal N; Tripathi N; Turner PV; Troth SP
    Toxicol Pathol; 2019 Oct; 47(7):789-798. PubMed ID: 31648619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically modified foods: hazard identification and risk assessment. Session summary.
    Ito N
    Exp Toxicol Pathol; 2002 Jul; 54(1):57-9. PubMed ID: 12180803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the toxicologic pathologist in the biopharmaceutical industry.
    van Tongeren S; Fagerland JA; Conner MW; Diegel K; Donnelly K; Grubor B; Lopez-Martinez A; Bolliger AP; Sharma A; Tannehill-Gregg S; Turner PV; Wancket LM
    Int J Toxicol; 2011 Oct; 30(5):568-82. PubMed ID: 21878555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary activities of Toxicologic Pathology Societies.
    Maronpot RR; Dagli MLZ
    J Toxicol Pathol; 2020 Jan; 33(1):57-63. PubMed ID: 32051667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary Activities of Toxicologic Pathology Societies.
    Maronpot RR; Dagli MLZ
    Toxicol Pathol; 2020 Feb; 48(2):295-301. PubMed ID: 31645226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Society of Toxicologic Pathology: Advances and Adventures in the First 50 Years.
    Hoenerhoff M; Fossey S; Keenan C; Bédard A; Lejeune T; Kerns W; Patrick D; Quist E; Bolon B
    Toxicol Pathol; 2021 Dec; 49(8):1326-1343. PubMed ID: 34414826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression, biomarkers, and glial cells in nervous system diseases.
    Sills RC; Garman RH
    Toxicol Pathol; 2011 Jan; 39(1):97-8. PubMed ID: 21147932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter on behalf of the European College of Veterinary Clinical Pathology in response to the article "International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies".
    Bonfanti U; O'Brien P; Pinches M; Poitout F; Stirn M; von Beust B
    Exp Toxicol Pathol; 2012 Mar; 64(3):267. PubMed ID: 20833518
    [No Abstract]   [Full Text] [Related]  

  • 32. Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies.
    Burkhardt JE; Pandher K; Solter PF; Troth SP; Boyce RW; Zabka TS; Ennulat D
    Toxicol Pathol; 2011 Dec; 39(7):1129-37. PubMed ID: 22116771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical Strategies for Navigating Toxicologic Pathology in One's Early Career…and Beyond!
    Carreira V; Palanisamy G; Quist E; Nelson K; Fossey S; Zimmerman B; Ramaiah L; Schafer KA
    Toxicol Pathol; 2018 Dec; 46(8):1037-1048. PubMed ID: 30352538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et. al.
    Tripathi NK
    Toxicol Pathol; 2010 Dec; 38(7):1167. PubMed ID: 21248324
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential of organoids in toxicologic pathology: role of toxicologic pathologists in
    Yoshida T; Kobayashi M; Uomoto S; Ohshima K; Hara E; Katoh Y; Takahashi N; Harada T; Usui T; Elbadawy M; Shibutani M
    J Toxicol Pathol; 2022 Jul; 35(3):225-235. PubMed ID: 35832897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies.
    Keirstead ND; Janovitz EB; Meehan JT; LeRoy BE; Megill JR; Peterson RA; Masson RG; Marxfeld HA
    Toxicol Pathol; 2019 Jun; 47(4):461-468. PubMed ID: 31018785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the European Society of Toxicologic Pathology Survey on the Use of Artificial Intelligence in Toxicologic Pathology.
    Palazzi X; Barale-Thomas E; Bawa B; Carter J; Janardhan K; Marxfeld H; Nyska A; Saravanan C; Schaudien D; Schumacher VL; Spaet RH; Tangermann S; Turner OC; Vezzali E
    Toxicol Pathol; 2023 Jun; 51(4):216-224. PubMed ID: 37732701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of an electronic program for pathologist training in the interpretation of a complex companion diagnostic immunohistochemical assay.
    Dennis E; Banks P; Murata LB; Sanchez SA; Pennington C; Hockersmith L; Miller R; Lambe J; Feng J; Kapadia M; Clements J; Loftin I; Singh S; Das-Gupta A; Lloyd W; Bloom K
    Hum Pathol; 2016 Oct; 56():194-203. PubMed ID: 27349303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics.
    Papenfuss TL; Himmel L; Kuper CF; Mohanan S; Harleman J; Elmore SA
    Toxicol Pathol; 2023 Jun; 51(4):205-215. PubMed ID: 37578155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IT/QA and Regulatory Aspects of Digital Pathology: Results of the 8th ESTP International Workshop.
    Boisclair J; Bawa B; Barale-Thomas E; Bertrand L; Carter J; Crossland R; Dorn C; Forest T; Grote S; Gilis A; Hildebrand D; Knight B; Laurent S; Marxfeld HA; Østergaard SJ; Roguet T; Schlueter T; Schumacher V; Spehar R; Varady W; Zeugin C
    Toxicol Pathol; 2022 Aug; 50(6):793-807. PubMed ID: 35950710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.